(Q34530710)

English

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

W Ripley Ballou

34

object named as

W Ripley Ballou

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

36

object named as

Johan Vekemans

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

24

object named as

Marc Lievens

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christian F Ockenhouse

35

object named as

Christian F Ockenhouse

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Silas A Davidson

11

object named as

Silas A Davidson

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Jason A Regules

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Susan B Cicatelli

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jason W Bennett

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kristopher M Paolino

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Patrick S Twomey

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

James E Moon

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

April K Kathcart

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kevin D Hauns

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jack L Komisar

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Aziz N Qabar

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sheetij Dutta

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Matthew E Griffith

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Charles D Magee

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mariusz Wojnarski

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jeffrey R Livezey

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Adrian T Kress

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Paige E Waterman

18

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Erik Jongert

19

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ulrike Wille-Reece

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Wayne Volkmuth

21

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Daniel Emerling

22

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

William H Robinson

23

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Danielle Morelle

25

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cynthia K Lee

26

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bebi Yassin-Rajkumar

27

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Richard Weltzin

28

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Joe Cohen

29

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Robert M Paris

30

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Norman C Waters

31

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ashley J Birkett

32

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

David C Kaslow

33

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

13 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

214

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

762-771

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

From the circumsporozoite protein to the RTS, S/AS candidate vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of plasmodium by amplifying RNA and DNA of the 18S rRNA genes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Recent developments in malaria vaccinology

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Germinal center selection and the development of memory B and plasma cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Can successful vaccines teach us how to induce efficient protective immune responses?

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Safety and efficacy of the RTS, S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Sense and the science of childhood immunization: can we achieve more with less?

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

The march toward malaria vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Accelerated hepatitis B vaccination schedule in childhood

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW237

21 January 2018

Identifiers

10.1093/INFDIS/JIW237

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34530710&oldid=1951875015"